Pharmosa Biopharm Inc. Stock Price

TPEX:6875 Community·NT$5.4b Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

6875 Share Price Performance

NT$41.65

-9.55 (-18.65%)

NT$41.65

-9.55 (-18.65%)

NT$41.65

Fri, 13 Mar 26

Share Pricen/a

6875 Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Flawless balance sheet with minimal risk.

1 Risk

1 Reward

View Full Analysis

Pharmosa Biopharm Inc. Key Details

Last Reported Earnings

Sep 30, 2025

Next Reporting Earnings

n/a

: -1.84
: 85.52%
: -173.89%
: 0%

View Full Analysis

About 6875

Founded: 2000
Employees: n/a
CEO: Pei Kan
WebsiteView website: www.pharmosa.com.tw

Pharmosa Biopharm Inc., a biotechnology company, focuses on developing drugs in Taiwan. It develops L606, an inhalation/device combination for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease; and L608, an inhalation/device combination for the treatment of pulmonary vascular disease. The company was formerly known as Pharmosa Limited and changed its name to Pharmosa Biopharm Inc. in October 2016. Pharmosa Biopharm Inc. was founded in 2000 and is headquartered in Taipei, Taiwan.